Annual Report

Aldeyra Therapeutics, Inc. Filed 2020-03-12 Acc 0001564590-20-010493

Documents 1

2021-03-11 10-K Annual Report
2020-03-17 4 Director bought 40,000 shares at $2.75 ($110,000)
2020-03-12 10-K Annual Report
2020-03-12 S-8 Securities Offered to Employees in Benefit Plans
2020-03-12 8-K Results of operations · Executive or director change · Other events
2020-03-06 4/A Chief Financial Officer acquired 137,707 shares (grant or award)
2019-03-08 10-K Annual Report

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading aldx-10k_20191231.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…